AbbVie reconsidering deal with Shire

SHARE AbbVie reconsidering deal with Shire

The North Chicago-based drugmaker is having second thoughts about its $55 billion deal to combine with British counterpart Shire. AbbVie said late Tuesday its board needs to weigh whether it is still a good idea in light of new U.S. tax regulations aimed at cracking down on corporate inversions. Shire called on AbbVie to stick to the deal, reminding its partner about the hefty $1.64 billion breakup fee.

Continue reading at Newsfeed

The Latest
The man, 22, was shot in the chest. The time and location of the shooting were not known.
Notes: Manager Craig Counsell reveals rehab outing plan for Jordan Wicks.
It’s a frustrating, unsatisfying time to be a baseball fan in Chicago no matter where your allegiance lies.
Even with shifting priorities, the school district says it has successfully maintained the funding it provides to schools overall.